Skip to main content

Table 3 Total cost* for patients included in the study with diagnosis of herpes zoster by age subgroups

From: Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the valencian community of Spain

 

TPP perspective**

Societal perspective‡

Age

Total

Mean

SD

Total

Mean

SD

   < 50 years

6,131.76

211.44

166.60

9,059.86

312.41

360.52

   50-59 years

7,170.86

239.03

231.48

11,235.57

374.52

485.30

   60-69 years

8,652.79

432.64

434.52

10,426.75

521.34

626.65

   ≥ 70 years

18,278.50

358.40

329.37

18,437.69

361.52

330.04

Total

40,233.91

309.49

307.47

49,159.86

378.15

430.67

 

P = 0.027

P = 0.401

  1. * In 2007 Euros.
  2. ** TPP Perspective (Third-Party Payer = Spanish Social Security): public medical visits + diagnostic test + percentage that Spanish National Health System pays for prescriptions.
  3. ‡ Societal perspective: TPP perspective items + percentage that patient pay for prescription + private medical visits + medication not included in the Spanish National System + cost for lost hours of work.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us